 |
|
Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
Bon San Koo, Seokchan Hong, You Jae Kim, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo
Korean J Intern Med. 2015;30(1):104-109. Published online 2014 Dec 30 DOI: https://doi.org/10.3904/kjim.2015.30.1.104
|
|
Citations to this article as recorded by
 Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry
Hong Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim
Therapeutic Advances in Musculoskeletal Disease.2024;[Epub] CrossRef Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development
Eunji Jeong, Hyunseok Hong, Yeon-Ah Lee, Kyoung-Soo Kim
International Journal of Molecular Sciences.2024; 25(5): 2682. CrossRef Efficacy and Safety of Conventional Synthetic, Biologic and Targeted Synthetic DMARDs in RA-ILD: A Narrative Review
Richard Conway, Elena Nikiphorou
Indian Journal of Rheumatology.2023; 18(4): 303. CrossRef Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study
Sun-Kyung Lee, Kichul Shin, Ju-Yang Jung, Chang-Hee Suh, Ji-Won Kim, Hyoun-Ah Kim
BioDrugs.2023; 37(2): 247. CrossRef Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
Haoming Yuan, Shaoxin Cui, Lin Yang, Jiehan Cui, Xiaoping Wang, Meng Ding, Lu Jin, Yanru Wang, Fei Chang, Hongtao Jin, Jun Ma, Min Shi, Aijing Liu
RMD Open.2023; 9(4): e003487. CrossRef Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón
Reumatología Clínica.2022; 18(9): 501. CrossRef SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón
Reumatología Clínica (English Edition).2022; 18(9): 501. CrossRef Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
E. L. Nasonov, L. P. Ananyeva, S. N. Avdeev
Rheumatology Science and Practice.2022; 60(6): 517. CrossRef Revisión sistemática sobre el impacto de los fármacos en la enfermedad pulmonar intersticial difusa asociada a Artritis Reumatoide
Carmen Carrasco Cubero, Eugenio Chamizo Carmona, Paloma Vela Casasempere
Reumatología Clínica.2021; 17(9): 504. CrossRef Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*
Adelle S. Jee, Robert Sheehy, Peter Hopkins, Tamera J. Corte, Christopher Grainge, Lauren K. Troy, Karen Symons, Lissa M. Spencer, Paul N. Reynolds, Sally Chapman, Sally de Boer, Taryn Reddy, Anne E. Holland, Daniel C. Chambers, Ian N. Glaspole, Helen E.
Respirology.2021; 26(1): 23. CrossRef Systematic review of the impact of drugs on diffuse interstitial lung disease associated with rheumatoid arthritis
Carmen Carrasco Cubero, Eugenio Chamizo Carmona, Paloma Vela Casasempere
Reumatología Clínica (English Edition).2021; 17(9): 504. CrossRef Mini Review: Pulmonary Toxicity Secondary to Immunosuppressive Agents in the Treatment of Rheumatoid Arthritis.
SunKrist Journal of Orthopedics and Musculoskeletal Disorders.2021; : 1. CrossRef Mortality in Korean Patients With Rheumatoid Arthritis
Yeon-Kyung Lee, Sang-Cheol Bae
Journal of Rheumatic Diseases.2021; 28(3): 113. CrossRef The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application
Yukai Wang, Shaoqi Chen, Shaoyu Zheng, Jianqun Lin, Shijian Hu, Jinghua Zhuang, Qisheng Lin, Xuezhen Xie, Kedi Zheng, Weijin Zhang, Guangzhou Du, Guohong Zhang, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, Daniel E. Furst
Arthritis Research & Therapy.2021;[Epub] CrossRef Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
Meihua Qiu, Jing Jiang, Xueyuan Nian, Yutie Wang, Pengfei Yu, Jie Song, Shenchun Zou
Respiratory Research.2021;[Epub] CrossRef Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
Giulia Cassone, Andreina Manfredi, Caterina Vacchi, Fabrizio Luppi, Francesca Coppi, Carlo Salvarani, Marco Sebastiani
Journal of Clinical Medicine.2020; 9(4): 1082. CrossRef The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
Christopher R Holroyd, Rakhi Seth, Marwan Bukhari, Anshuman Malaviya, Claire Holmes, Elizabeth Curtis, Christopher Chan, Mohammed A Yusuf, Anna Litwic, Susan Smolen, Joanne Topliffe, Sarah Bennett, Jennifer Humphreys, Muriel Green, Jo Ledingham
Rheumatology.2019; 58(2): e3. CrossRef Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)
Adelle S. Jee, Tamera J. Corte
Drugs.2019; 79(14): 1511. CrossRef Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology
Emily K. Wu, Robert D. Ambrosini, R. Matthew Kottmann, Christopher T. Ritchlin, Edward M. Schwarz, Homaira Rahimi
Current Rheumatology Reviews.2019; 15(4): 277. CrossRef Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies
Juan Chen, Shuhong Chi, Feng Li, Jiali Yang, William C. Cho, Xiaoming Liu
Expert Opinion on Biological Therapy.2017; 17(3): 265. CrossRef Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist’s point of view
So-My Koo, Soo-Taek Uh
The Korean Journal of Internal Medicine.2017; 32(4): 600. CrossRef Acute Respiratory Events in Connective Tissue Disorders
Spyros A. Papiris, Effrosyni D. Manali, Likurgos Kolilekas, Konstantinos Kagouridis, Maria Maniati, Gerasimos Filippatos, Demosthenes Bouros
Respiration.2016; 91(3): 181. CrossRef Adalimumab/etanercept
Reactions Weekly.2015; 1577(1): 17. CrossRef Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis
Shunsuke Mori
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine.2015; 9s1: CCRPM.S23288. CrossRef
|